To obtain short-term and long-term clinical safety information, in pediatric and adult patients with PA and MMA treated with CarbagluĀ®.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Effects of CarbagluĀ® on plasma ammonia levels
Timeframe: Patients treated with CarbagluĀ® will be managed chronically (out-patient) or acutely (hospital in-patient). In both cases, data will be collected for approximately 1 year following discontinuation of Carbaglu treatment.
Adverse Event frequency and severity
Timeframe: Patients treated with CarbagluĀ® will be managed chronically (out-patient) or acutely (hospital in-patient). In both cases, data will be collected for approximately 1 year following discontinuation of Carbaglu treatment.